Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.34 |
| ▸ | MAOA | P21397 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CASP6 | P55212 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.34 |
| ▸ | SORD | Q00796 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15959787 | 1.00 | NPSR1 (0.38) | NPSR1RXFP1PDK2ESR2MAOA | |
| SCHEMBL17789542 | 0.94 | PDK2 (0.43) | NPSR1RXFP1PDK2ESR2POLB | |
| SCHEMBL20011331 | 0.79 | HTR2A (0.38) | PDK2ESR2MEN1KMT2AESR1 | |
| SCHEMBL17929494 | 0.79 | PDK2 (0.45) | NPSR1RXFP1PDK2ESR2MAOA | |
| SCHEMBL1683947 | 0.78 | NPSR1 (0.52) | NPSR1RXFP1ESR2MAOAPOLB | |
| SCHEMBL1615354 | 0.78 | NPSR1 (0.52) | NPSR1RXFP1ESR2MAOAPOLB | |
| SCHEMBL2020199 | 0.78 | NPSR1 (0.52) | NPSR1RXFP1ESR2MAOAPOLB | |
| SCHEMBL17789546 | 0.77 | PDE4B (0.35) | RXFP1PDK2POLBMEN1KMT2A | |
| SCHEMBL15959755 | 0.76 | MAPT (0.44) | PDK2MAOAPOLBMEN1KMT2A | |
| SCHEMBL15959737 | 0.76 | MAPT (0.44) | PDK2MAOAPOLBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-07-14 | — | — | US | disclosed |
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-07-14 | — | — | US | disclosed |
| US-9166177-B2 | Ditriphenylene derivative and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2015-10-20 | — | — | US | disclosed |
| US-9166177-B2 | Ditriphenylene derivative and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2015-10-20 | — | — | US | disclosed |
| US-20140231754-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Yen, Feng-wen (TW) | 2014-08-21 | — | — | US | disclosed |
| US-20140231754-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Yen, Feng-wen (TW) | 2014-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | NR2E1, NR0B1, NR2E3 | NPSR1 663/4885RXFP1 569/4885PDK2 3472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.